WHO ICTRP trial

LOCAL INVASIVE TREATMENT OF TRAPEZIUS MUSCLE PAIN IN PATIENTS WITH FIBROMYALGIA

CTIS2024-520345-23-00 · EU Clinical Trials Information System · Not Recruiting

Key facts

Trial ID CTIS2024-520345-23-00
Public title LOCAL INVASIVE TREATMENT OF TRAPEZIUS MUSCLE PAIN IN PATIENTS WITH FIBROMYALGIA
Scientific title EFFICACY AND SAFETY OF LOCAL TREATMENT OF TRAPEZIUS MYOFASCIAL SYNDROME IN PATIENTS WITH FIBROMYALGIA THROUGH ULTRASOUND-GUIDED INTERFASCIAL BLOCK OF THE TRAPEZIUS MUSCLE - TRAPEZIUS
Primary sponsor Fundacio De Recerca Clinic Barcelona-Institut D’Investigacions Biomediques August Pi I Sunyer
Registry EU Clinical Trials Information System
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): No Therapeutic exploratory (Phase II): No Therapeutic confirmatory - (Phase III): No Therapeutic use - (Phase IV): Yes
Countries Spain
Conditions TRAPEZIUS MYOFASCIAL SYNDROME IN FIBROMYALGIA PATIENTS;Therapeutic area: Analytical, Diagnostic and Therapeutic Techniques and Equipment [E] - Anesthesia and Analgesia [E03]
Interventions Product Name: KENACORT 40 mg/ml sospensione iniettabile, Product Code:PRD363662, Pharmaceutical Form: SUSPENSION FOR INJECTION, Other descriptive name: , Strength: , Product Name: Suero Fisiológico Braun 0,9% disolvente para uso parenteral…
Registration date Dec 24, 2024
Target size 69
Secondary IDs 2022-002717-41
Registry page euclinicaltrials.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations